These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35648812)

  • 21. Pathology and Pathogenesis of Yersinia pestis.
    Du Z; Wang X
    Adv Exp Med Biol; 2016; 918():193-222. PubMed ID: 27722864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The responses of lungs and adjacent lymph nodes in responding to Yersinia pestis infection: A transcriptomic study using a non-human primate model.
    Chakraborty N; Gautam A; Muhie S; Miller SA; Moyler C; Jett M; Hammamieh R
    PLoS One; 2019; 14(2):e0209592. PubMed ID: 30789917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model.
    Gur D; Glinert I; Aftalion M; Vagima Y; Levy Y; Rotem S; Zauberman A; Tidhar A; Tal A; Maoz S; Ber R; Pass A; Mamroud E
    Front Microbiol; 2018; 9():741. PubMed ID: 29740404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardized Method for Aerosol Challenge of Rodents with Yersinia pestis for Modeling Primary Pneumonic Plague.
    Anderson PE; Olson RM; Willix JL; Anderson DM
    Methods Mol Biol; 2019; 2010():29-39. PubMed ID: 31177429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague.
    Zauberman A; Tidhar A; Levy Y; Bar-Haim E; Halperin G; Flashner Y; Cohen S; Shafferman A; Mamroud E
    PLoS One; 2009 Jun; 4(6):e5938. PubMed ID: 19529770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postexposure Administration of a Yersinia pestis Live Vaccine for Potentiation of Second-Line Antibiotic Treatment Against Pneumonic Plague.
    Zauberman A; Gur D; Levy Y; Aftalion M; Vagima Y; Tidhar A; Chitlaru T; Mamroud E
    J Infect Dis; 2019 Aug; 220(7):1147-1151. PubMed ID: 31095689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague.
    Sha J; Rosenzweig JA; Kirtley ML; van Lier CJ; Fitts EC; Kozlova EV; Erova TE; Tiner BL; Chopra AK
    Microb Pathog; 2013 Feb; 55():39-50. PubMed ID: 23063826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase.
    Gibson EG; Bax B; Chan PF; Osheroff N
    ACS Infect Dis; 2019 Apr; 5(4):570-581. PubMed ID: 30757898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early emergence of Yersinia pestis as a severe respiratory pathogen.
    Zimbler DL; Schroeder JA; Eddy JL; Lathem WW
    Nat Commun; 2015 Jun; 6():7487. PubMed ID: 26123398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plazomicin is effective in a non-human primate pneumonic plague model.
    Mega WM; Doyle-Eisele M; Cass RT; Kostrub CF; Sherwood RL; Metz MA; Cirz RT
    Bioorg Med Chem; 2016 Dec; 24(24):6429-6439. PubMed ID: 27614915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Yersinia pestis and plague - an update].
    Stock I
    Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of the Pulmonary MyD88 Inflammatory Response Underlies the Role of the Yersinia pestis Pigmentation Locus in Primary Pneumonic Plague.
    Olson RM; Dhariwala MO; Mitchell WJ; Skyberg JA; Anderson DM
    Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33257532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiological Analysis from a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae.
    Scangarella-Oman NE; Hossain M; Dixon PB; Ingraham K; Min S; Tiffany CA; Perry CR; Raychaudhuri A; Dumont EF; Huang J; Hook EW; Miller LA
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections.
    Scangarella-Oman NE; Hossain M; Hoover JL; Perry CR; Tiffany C; Barth A; Dumont EF
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0149221. PubMed ID: 34978887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague.
    Tiner BL; Sha J; Kirtley ML; Erova TE; Popov VL; Baze WB; van Lier CJ; Ponnusamy D; Andersson JA; Motin VL; Chauhan S; Chopra AK
    Infect Immun; 2015 Apr; 83(4):1318-38. PubMed ID: 25605764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection.
    D'Arco C; McCormick AA; Arnaboldi PM
    Vaccine; 2021 Mar; 39(9):1435-1444. PubMed ID: 33531196
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Steenbergen J; Tanaka SK; Miller LL; Halasohoris SA; Hershfield JR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of inflammation and pneumonia during infection with nonpigmented Yersinia pestis reveals a new role for the pgm locus in pathogenesis.
    Lee-Lewis H; Anderson DM
    Infect Immun; 2010 Jan; 78(1):220-30. PubMed ID: 19841077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation.
    Layton RC; Brasel T; Gigliotti A; Barr E; Storch S; Myers L; Hobbs C; Koster F
    J Med Primatol; 2011 Feb; 40(1):6-17. PubMed ID: 20722770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gepotidacin (GSK2140944)
    Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.